From professional translators, enterprises, web pages and freely available translation repositories.
no subject
bez temata
Last Update: 2012-02-15
Usage Frequency: 4
Quality:
(no subject)
(no subject)
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
no subject specified
nav norādīts temats
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
10:49p (no subject)
temats:
Last Update: 2018-02-13
Usage Frequency: 6
Quality:
(no subject) @ 02:11 pm
temats:
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
no subject had a qtcf >450 msec.
nevienam dalībniekam nebija qtcf >450 ms.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
Warning: Contains invisible HTML formatting
11:15a (no subject) - 1 reply
temats:
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
no subject received a blood transfusion.
nevienam dalībniekam netika pārlietas asinis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
12:10 pm: (no subject) - 1 comment
1.
Last Update: 2018-02-13
Usage Frequency: 1
Quality:
no subject discontinued the studies due to adverse events.
neviens pacients nepārtrauca pētījumu blakusparādību dēļ.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
no subject discontinued the study due to an adverse event.
neviens pacients blakusparādību dēļ nepārtrauca dalību pētījumā.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
no subject in either group showed emergence of protease inhibitor resistance.
nevienam no abu grupu pacientiem neradās proteāzes inhibitoru rezistence.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
no subject in any group had an increase in qtc of ≥60 msec from baseline.
nevienam subjektam nevienā no grupām netika konstatēts qtc pagarinājums par – 60 ms salīdzinājumā ar sākumstāvokli.
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
no subject experienced an interval exceeding the potentially clinically relevant threshold of 500 msec.
nevienam no subjektiem netika sasniegts potenciālais klīniskais slieksnis, proti, 500 ms.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
no episodes of major hypoglycaemia were reported, and no subject discontinued the study treatment due to hypoglycaemia.
par smagas hipoglikēmijas gadījumiem netika ziņots, un hipoglikēmijas dēļ pētāmo zāļu lietošanu nepārtrauca neviens pacients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
no subject experienced an increase in qtcf of 60 msec from baseline or a qtcf interval exceeding the potentially clinically relevant threshold of 500 msec.
nevienam dalībniekam qtcf nepalielinājās par 60 msec no sākotnējā vai qtcf intervāls nepārsniedza potenciāli klīniski nozīmīgo 500 msec slieksni.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
no subject experienced an increase in qtcf of ≥ 60 msec from baseline or a qtcf interval exceeding the potentially clinically relevant threshold of 500 msec.
nevienam no subjektiem qtcf nepalielinājās ≥ 60 msec, salīdzinot ar sākumstāvokli, un qtcf intervāls nepārsniedza potenciāli klīniski nozīmīgo 500 msec slieksni.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
we agreed to discuss nuclear issues and we accepted that these are a subject to be debated between us, because it was made clear from the beginning that no subject was taboo.
mēs piekritām apspriest kodolenerģijas jautājumus, un mēs piekritām, ka tā ir tēma, kas apspriežama starp mums, jo bija skaidrs jau no paša sākuma, ka neviena tēma nav tabu.
Last Update: 2012-03-01
Usage Frequency: 4
Quality:
we must have a challenging dialogue with china where no subject is taboo, and we must encourage it to make commitments in all areas, in the political, human rights and social fields.
mums ir jārisina stimulējošs dialogs ar Ķīnu, kur neviens temats nav tabu, un mums tā ir jāmudina uzņemties saistības visās jomās - politiskajā, cilvēktiesību un sociālajā.
Last Update: 2012-03-01
Usage Frequency: 4
Quality:
no subjects developed new clinically relevant ecg morphological changes following administration of amifampridine phosphate.
pēc amifampridīna fosfāta lietošanas jaunas, klīniski nozīmīgas morfoloģiskas izmaiņas ekg neattīstījās nevienam pacientam.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: